Statistics & Data selects MedNet iMedNet EDC solution
iMedNet EDC system, which provides a suite of intuitive and easy-to-use designer tools, allows sponsors, CROs and investigators to set up entire studies within seconds, without depending on
The European Commission (EC) has approved an extended use of Johnson & Johnson’s Tecvayli (teclistamab), along with daratumumab, to treat adult patients with relapsed or refractory multiple myeloma (r/r MM).